Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth.

Haridas V, Shrivastava A, Su J, Yu GL, Ni J, Liu D, Chen SF, Ni Y, Ruben SM, Gentz R, Aggarwal BB.

Oncogene. 1999 Nov 11;18(47):6496-504.

2.

Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.

Gaur U, Aggarwal BB.

Biochem Pharmacol. 2003 Oct 15;66(8):1403-8. Review.

PMID:
14555214
3.

TNF-R1 signaling: a beautiful pathway.

Chen G, Goeddel DV.

Science. 2002 May 31;296(5573):1634-5. Review.

PMID:
12040173
4.

Advancement in the research on vascular endothelial growth inhibitor (VEGI).

Duan L, Yang G, Zhang R, Feng L, Xu C.

Target Oncol. 2012 Mar;7(1):87-90. doi: 10.1007/s11523-012-0206-0. Epub 2012 Mar 3. Review.

PMID:
22388993
5.

Therapeutic Potential of VEGI/TL1A in Autoimmunity and Cancer.

Sethi G, Sung B, Aggarwal BB.

Adv Exp Med Biol. 2009;647:207-15. doi: 10.1007/978-0-387-89520-8_15. Review.

PMID:
19760077
7.

[Progress in research of TROY, a member of TNF receptor superfamily].

Huang JY, Lu PH.

Sheng Li Ke Xue Jin Zhan. 2008 Jul;39(3):261-3. Review. Chinese. No abstract available.

PMID:
18819499

Supplemental Content

Support Center